- Home
- CGTX vs FORA Comparison
CGTX vs FORA Comparison
Compare CGTX & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- FORA
- Stock Information
- Founded
- CGTX 2007
- FORA 2014
- Country
- CGTX United States
- FORA United States
- Employees
- CGTX N/A
- FORA N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- CGTX Health Care
- FORA Technology
- Exchange
- CGTX Nasdaq
- FORA Nasdaq
- Market Cap
- CGTX 53.4M
- FORA 60.2M
- IPO Year
- CGTX 2021
- FORA N/A
- Fundamental
- Price
- CGTX $1.54
- FORA $2.00
- Analyst Decision
- CGTX Strong Buy
- FORA Strong Buy
- Analyst Count
- CGTX 3
- FORA 1
- Target Price
- CGTX $2.83
- FORA $5.00
- AVG Volume (30 Days)
- CGTX 8.5M
- FORA 14.0K
- Earning Date
- CGTX 08-07-2025
- FORA 08-13-2025
- Dividend Yield
- CGTX N/A
- FORA N/A
- EPS Growth
- CGTX N/A
- FORA N/A
- EPS
- CGTX N/A
- FORA N/A
- Revenue
- CGTX N/A
- FORA $25,031,040.00
- Revenue This Year
- CGTX N/A
- FORA $46.25
- Revenue Next Year
- CGTX N/A
- FORA $11.30
- P/E Ratio
- CGTX N/A
- FORA N/A
- Revenue Growth
- CGTX N/A
- FORA 18.59
- 52 Week Low
- CGTX $0.22
- FORA $1.85
- 52 Week High
- CGTX $1.97
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- CGTX 77.80
- FORA 55.72
- Support Level
- CGTX $1.15
- FORA $1.92
- Resistance Level
- CGTX $0.74
- FORA $2.00
- Average True Range (ATR)
- CGTX 0.19
- FORA 0.06
- MACD
- CGTX 0.09
- FORA 0.01
- Stochastic Oscillator
- CGTX 69.59
- FORA 47.83
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.